Latest News & Features
Big Pharma
UK judge concludes neither party has ‘won’ in case between Salts and Pelican over ostomy products | Court denied Salts’ request for Model D disclosure. 25 June 2024
Americas
Magistrate stand-in not authorised to answer jury questions, says eleventh circuit in precedential opinion | Florida judge left to catch flight before verdict given | Dispute between shrimp breeders concerns “unique” breeding method. 20 June 2024
Americas
Can the FTC push through a law that has perturbed America’s life sciences industry? Unlikely, says the lawyer appointed by the world’s largest HR group opposing the move. 20 June 2024
Americas
South Korean firm has sued two manufacturers in Delaware alleging patent infringement | SKBP asked court to stop ANDAs from Aurobindo and Zenara until patents expire. 19 June 2024
Big Pharma
Judge says lower court abused discretion when issuing injunction | Negative impact of potential Medtronic deal on Insulet was “mere conjecture”. 18 June 2024
Europe
Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford explore. 18 June 2024
Big Pharma
New Jersey court grants 30-day stay days after ordering the removal of five patents for asthma inhalers from FDA Orange Book | Decision follows ruling favouring Amneal Pharmaceuticals, which argued the patents were improperly listed. 18 June 2024
Biotechnology
Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for cancer diagnostics. 13 June 2024
Biotechnology
Finnish health tech firm says Ultrahuman’s motion to stay would significantly prejudice case | Oura claims Indian company trying to circumvent ITC exclusion order. 13 June 2024
Big Pharma
New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies. 13 June 2024